Thrombospondin 4 A1
血小板反应蛋白 4 A1
基本信息
- 批准号:7851211
- 负责人:
- 金额:$ 70.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdhesionsAffectAlanineAmino AcidsApoptosisAreaArthritisAspartic AcidBehaviorBindingBinding SitesC-terminalCalciumCalcium BindingCartilageCell AdhesionCell Surface ProteinsCell physiologyCell surfaceCellsCellular StructuresChondrocytesCoinCollagenCollagen FibrilComprehensionCuesDataDevelopmentEnvironmentEpiphysial cartilageExtracellular MatrixFamilyFibroblastsFibronectinsGene FamilyGenesGlycosaminoglycansGoalsIndividualInflammationIntegrin BindingIntegrinsIonsKnockout MiceLeadMMP9 geneMediatingMetalsMolecularMutagenesisMutateMutationNeoplasm MetastasisPeptide HydrolasesPeptide LibraryPhenotypePhysiologicalProcessProtein BindingProteinsProteoglycanPseudoachondroplastic spondyloepiphyseal dysplasia syndromePublishingRecombinantsRegulationResearchRoleScaffolding ProteinSeriesSignal PathwaySiteSite-Directed MutagenesisSpecificityStimulusStructureSystemTHBS1 geneTechniquesThrombospondin 1ThrombospondinsTissuesWound HealingX-Ray CrystallographyZincaggrecanangiogenesisbasedisease-causing mutationinsightknock-downmammalian COMPmembermigrationprotein expressionprotein foldingprotein functionprotein structurerepairedresponsesignature moleculeskeletal dysplasiasynthetic peptidethrombospondin 3thrombospondin 4tumor
项目摘要
A detailed comprehension of the role of the thrombospondins (TSPs), including cartilage oligomeric matrix protein (COMP), in the regulation of extracellular matrix (ECM) structure and cellular behavior during tissue genesis and repair is the long-term goal of the proposed studies. Specific focus for the next period of support will be on the following areas. Specific Aim 1. To identify key amino acids for the interactions of COMP with proteins and proteoglycans (PGs). We have found that COMP binds to aggrecan, as well as to integrins in chondrocytes and fibroblasts. In addition, growth plate disorganization is observed in TSP-1-, TSP-3-, and COMP-null mice. We have recently solved the structure of the signature domain of COMP by X-ray crystallography. Based on these data, we plan to determine the molecular basis for the interaction of COMP with collagens, integrins, and glycosaminoglycans (GAGs) by site-directed mutagenesis within the context of the intact molecule and the recombinant signature domain. The aspartic acids that comprise the potential metal ion-dependent adhesion site (MIDAS) and the adjacent to MIDAS motif will be mutated to alanines to establish the importance of these sites in collagen and zinc binding, and matrix assembly. In addition, the specificity of the MIDAS will be explored using peptide libraries. The binding site for GAGs will be identified by X-ray crystallography. Existing structural data, naturally occurring mutations, and published synthetic peptide data will be used to identify amino acids for mutagenesis. This approach will enable us to probe the function of specific motifs within the context of the correctly folded protein. Specific Aim 2. To determine the effects of COMP on cellular phenotype and ECM structure. COMP orchestrates collagen fibril formation, ECM organization, and chondrocyte survival and differentiation during growth plate development. The importance of COMP is underscored by the fact that naturally occurring mutations in it result in skeletal dysplasias. In Aim 1, we will identify the integrin, collagen and GAG binding sites in the COMP molecule. In this aim, we will identify the integrin-mediated cellular responses to COMP in chondrocytes and fibroblasts. We will also explore the effect of the absence of COMP expression using primary cultures of chondrocytes from COMP-null mice. We hypothesize that wild-type COMP promotes cell adhesion, migration, proliferation and survival, while suppressing apoptosis. The specific signaling pathways that mediate the cellular responses to COMP in 2- and 3-D culture systems will be identified. In addition, proliferation, apoptosis and matrix structure in the growth plate of wild-type and COMP-null mice will be analyzed. We will also determine whether or not the integrin and GAG binding sites collaborate with the collagen-binding site to regulate ECM structure. Finally, we will explore the effect of some of the disease causing mutations on the ability of COMP to support cellular processes and matrix assembly. The data from these studies will provide key insights into the function of the signature domain of COMP in terms of its interactions with various proteins, PGs and cells.
详细了解血小板反应蛋白(TSP),包括软骨寡聚基质蛋白(COMP),在组织发生和修复过程中调节细胞外基质(ECM)结构和细胞行为的作用是拟议研究的长期目标。下一个支助期的具体重点将放在以下领域。具体目标1.确定COMP与蛋白质和蛋白聚糖(PG)相互作用的关键氨基酸。我们已经发现COMP与软骨细胞和成纤维细胞中的聚集蛋白聚糖以及整合素结合。此外,在TSP-1-、TSP-3-和COMP-敲除小鼠中观察到生长板解体。我们最近解决了COMP的签名域的结构,通过X射线晶体学。基于这些数据,我们计划确定COMP与胶原蛋白,整合素和糖胺聚糖(GAG)的相互作用的分子基础,通过定点诱变的背景下的完整分子和重组签名域。将包含潜在金属离子依赖性粘附位点(MIDAS)和邻近MIDAS基序的天冬氨酸突变为丙氨酸,以确定这些位点在胶原蛋白和锌结合以及基质组装中的重要性。此外,将使用肽库探索MIDAS的特异性。将通过X射线晶体学鉴定GAG的结合位点。现有的结构数据、天然存在的突变和已发表的合成肽数据将用于鉴定用于诱变的氨基酸。这种方法将使我们能够在正确折叠的蛋白质的背景下探测特定基序的功能。具体目标2。观察COMP对细胞表型和ECM结构的影响。COMP在生长板发育过程中协调胶原原纤维形成、ECM组织和软骨细胞存活和分化。COMP的重要性是由其天然发生的突变导致骨骼发育不良的事实所强调的。在目的1中,我们将鉴定COMP分子中的整合素、胶原和GAG结合位点。在这个目标中,我们将确定整合素介导的细胞反应,COMP在软骨细胞和成纤维细胞。我们还将使用来自COMP缺失小鼠的软骨细胞的原代培养物来探索COMP表达缺失的影响。我们推测野生型COMP促进细胞粘附、迁移、增殖和存活,同时抑制细胞凋亡。将确定在2-和3-D培养系统中介导细胞对COMP反应的特定信号传导途径。此外,还将分析野生型和COMP基因敲除小鼠生长板中的增殖、凋亡和基质结构。我们还将确定整合素和GAG结合位点是否与胶原结合位点协作来调节ECM结构。最后,我们将探讨一些致病突变对COMP支持细胞过程和基质组装能力的影响。这些研究的数据将为COMP的特征结构域在与各种蛋白质、PG和细胞相互作用方面的功能提供关键见解。
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The interaction of Thrombospondins with extracellular matrix proteins.
- DOI:10.1007/s12079-009-0074-2
- 发表时间:2009-12
- 期刊:
- 影响因子:4.1
- 作者:Tan, Kemin;Lawler, Jack
- 通讯作者:Lawler, Jack
A thrombospondin-dependent pathway for a protective ER stress response.
- DOI:10.1016/j.cell.2012.03.050
- 发表时间:2012-06-08
- 期刊:
- 影响因子:64.5
- 作者:Lynch JM;Maillet M;Vanhoutte D;Schloemer A;Sargent MA;Blair NS;Lynch KA;Okada T;Aronow BJ;Osinska H;Prywes R;Lorenz JN;Mori K;Lawler J;Robbins J;Molkentin JD
- 通讯作者:Molkentin JD
Thrombospondin-based antiangiogenic therapy.
- DOI:10.1016/j.mvr.2007.04.007
- 发表时间:2007-09
- 期刊:
- 影响因子:3.1
- 作者:Xuefeng Zhang;J. Lawler
- 通讯作者:Xuefeng Zhang;J. Lawler
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.
- DOI:10.1016/j.cell.2009.09.025
- 发表时间:2009-10-16
- 期刊:
- 影响因子:64.5
- 作者:Eroglu C;Allen NJ;Susman MW;O'Rourke NA;Park CY;Ozkan E;Chakraborty C;Mulinyawe SB;Annis DS;Huberman AD;Green EM;Lawler J;Dolmetsch R;Garcia KC;Smith SJ;Luo ZD;Rosenthal A;Mosher DF;Barres BA
- 通讯作者:Barres BA
Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication.
- DOI:10.1083/jcb.200206062
- 发表时间:2002-10-28
- 期刊:
- 影响因子:0
- 作者:Tan K;Duquette M;Liu JH;Dong Y;Zhang R;Joachimiak A;Lawler J;Wang JH
- 通讯作者:Wang JH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John W LAWLER其他文献
John W LAWLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John W LAWLER', 18)}}的其他基金
Inhibition of angiogenesis by thrombospondin-1 (A2)
血小板反应蛋白-1 (A2) 抑制血管生成
- 批准号:
8193192 - 财政年份:2009
- 资助金额:
$ 70.19万 - 项目类别:
Inhibition of angiogenesis by thrombospondin-1 (A2)
血小板反应蛋白-1 (A2) 抑制血管生成
- 批准号:
7876959 - 财政年份:2009
- 资助金额:
$ 70.19万 - 项目类别:
Inhibition of angiogenesis by thrombospondin-1 (A2)
血小板反应蛋白-1 (A2) 抑制血管生成
- 批准号:
8270525 - 财政年份:2009
- 资助金额:
$ 70.19万 - 项目类别:
Inhibition of angiogenesis by thrombospondin-1 (A2)
血小板反应蛋白-1 (A2) 抑制血管生成
- 批准号:
7650776 - 财政年份:2009
- 资助金额:
$ 70.19万 - 项目类别:
Thrombospondins and other Matricellular Proteins in Tissue Organization and Hemeo
组织组织和血红蛋白中的血小板反应蛋白和其他基质细胞蛋白
- 批准号:
7275863 - 财政年份:2007
- 资助金额:
$ 70.19万 - 项目类别:
Cell Biology and Multigene Transcriptional Profiling Core
细胞生物学和多基因转录分析核心
- 批准号:
8378445 - 财政年份:2002
- 资助金额:
$ 70.19万 - 项目类别:
Cell Biology and Multigene Transcriptional Profiling Core
细胞生物学和多基因转录分析核心
- 批准号:
8459039 - 财政年份:2002
- 资助金额:
$ 70.19万 - 项目类别:
Structure and Function of Thrombospondin-1
Thrombospondin-1 的结构和功能
- 批准号:
6625601 - 财政年份:2002
- 资助金额:
$ 70.19万 - 项目类别:
Structure and Function of Thrombospondin-1
Thrombospondin-1 的结构和功能
- 批准号:
6477678 - 财政年份:2002
- 资助金额:
$ 70.19万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 70.19万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 70.19万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 70.19万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 70.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 70.19万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 70.19万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 70.19万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 70.19万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 70.19万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 70.19万 - 项目类别:














{{item.name}}会员




